Why BIDMC for Hematology/Oncology Training
Benefits of a Fellowship at BIDMC
There are many reasons to select BIDMC for a Hematology/Oncology fellowship.
Beth Israel Deaconess Medical Center
BIDMC is one of the nation's preeminent academic medical centers. As an institution, it is committed to excellence in clinical care, biomedical research and education and to the health and wellness of our patients and our communities.
BIDMC's 1,250 full-time physicians constitute almost a quarter of Harvard Medical School's faculty. As a training hospital, BIDMC is committed to training the next generation of doctors and have raised medical education to a higher level with a uniquely strong and deep program that attracts top faculty and residents. Learning flourishes within the medical center's hallways, as students learn from the best of the best in an open environment that produces leaders of tomorrow.
BIDMC is also the official hospital of the Boston Red Sox, a partnership that promotes BIDMC’s community outreach and provides joint sponsorship for a youth scholarship program. BIDMC employees are eligible for $5, first-come-first-serve tickets to Red Sox games as well as volunteer opportunities at Red Sox-BIDMC sponsored community health events.
Read more about what makes BIDMC special.
Department of Medicine
In the words of Department Chair Dr. Mark Zeidel, “We train residents and fellows to provide the type of care they would want their families to have: compassionate, comprehensive, high quality and cutting edge.” With 300 diverse trainees, the Department of Medicine supports the graduate medical education of clinicians, teachers and investigators.
Led by an outstanding team of nationally prominent educators, the department provides highly innovative and effective residency and fellowship training programs, exceptional CME courses and teaching for Harvard medical students. The department has over 400 full-time faculty members. Among them are members of the National Academy of Sciences, the Institute of Medicine, the American Society for Clinical Investigation, the American Academy of Arts and Sciences, and fellows of the American Association for the Advancement of Science.
The department is highly regarded throughout Harvard Medical School for its teaching, and its faculty has garnered more teaching awards in recent years than any other department in the school. The department is proud to be part of a hospital that values education and is home to the Shapiro Institute for Medical Education as well as the first fully-accredited hospital-based simulation center.
Learn more about the Department of Medicine in annual reports.
Division of Hematology/Oncology
The Divisions are integral members of the BIDMC Cancer Center. In 2012, the Cancer Center became one the first academic medical centers nationwide—and the first in Boston—to attain QOPI (Quality Oncology Practice Initiative) Certification by the American Society of Clinical Oncology (ASCO) and has maintained certification with ongoing quality improvement evaluations and initiatives.
The Division’s faculty, along with Cancer Center colleagues in Surgery and Pathology, offer compassionate, leading-edge care through 20 specialty programs. We’re proud to provide exceptional care in our state-of-the-art ambulatory hematology/oncology center, where we receive over 51,000 patient visits per year.
Perhaps the most important perspective on the Division and the Fellowship Program comes directly from one of our Fellows in the Class of 2021:
“I feel incredibly fortunate to have had the opportunity to train in Hematology/Oncology at BIDMC. Through thoughtful design of the clinical program and dedication of the faculty to teaching and mentorship, BIDMC offers unparalleled, personalized training preparing graduates for success as clinicians and scientists. BIDMC also fosters a strong, positive culture amongst trainees and between trainees and faculty that ensures support during this essential phase of personal and career development.”
– A.J. Piper, Class of 2021
Learn more about the Divisions of Hematologic and Hematologic Malignancies and Medical Oncology.